- Advertisement -

 

Tidal ETF Services, a leading provider of ETF structuring, launch, and growth services, in partnership with Constrained Capital LLC (“Constrained Capital”), announced the launch of the Constrained Capital ESG Orphans ETF (ticker: ORFN), listed NYSE.

Constrained Capital is an ETF sponsor specializing in opportunistic investments that it believes to have high-expected return securities for better risk-adjusted returns. ORFN is an index fund, and the first of its kind to invest exclusively in the exclusions of Environmental, Social, and Governance (“ESG”) (i.e., “the Orphans”).

ORFN seeks to track the performance of the Constrained Capital ESG Orphans Index (“the Index”), before fees and expenses, while providing an alternative to traditional equity investments, in this case those specifically designed to capture of the excluded and orphaned sector of the ESG investment process. ORFN will invest all, or substantially all, of its assets in the components securities that make up the Index. The Index is comprised of US equity securities of publicly traded mid- and large-cap US-listed companies that are ESG Orphans (exclusions) defined by the Index.

“The explosion in the ESG investing movement over the past decade has yielded what I believe to be a generational opportunity in a contrarian, reversion theme, for opportunistically inclined, critical thinking investors,” said Mark Neuman, CFA, and creator of the Index. “The strategy is designed for all types of investors looking for a timely and alternative portfolio allocation.” For more information, visit esgorphans.com.

“We’re honored to work with a best-in-class partner like Constrained Capital, who saw a unique opportunity to bring to market a product which is contrarian in nature,” said Gavin Filmore, Head of Product at Tidal. “As a platform for innovative ETFs, we pride ourselves in partnering with issuers and index providers who view markets from a unique vantage point, Constrained Capital is a great example of just that.”

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here